Retrospective analysis of efficacy and safety of Gemcitabine-based chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX

類似資料

• Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma
  著者:: de Jesus, Victor Hugo Fonseca, 等
  出版事項: (2018)
• Costs of First-Line Treatment With FOLFIRINOX, Modified FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma
  著者:: Syvart Dennen, 等
  出版事項: (2025-08-01)
• Evaluation of gemcitabine efficacy after the FOLFIRINOX regimen in patients with advanced pancreatic adenocarcinoma
  著者:: Gilabert, Marine, 等
  出版事項: (2017)
• Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinoma
  著者:: Sarabi, Matthieu, 等
  出版事項: (2017)
• Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer
  著者:: de Jesus, Victor H. F., 等
  出版事項: (2020)